I agree. The lack of communication is concerning.
Are they not reporting progress or is no progress being made?
Either way, I don't like it.
The document linked below was published last week.
The decision itself is dated 13/3/23.
It states in the document:
"Date of completion of the paediatric investigation plan: By December 2023"
P/0080/2023 : EMA decision of 13 March 2023 on the acceptance of a modification of an agreed paediatric investigation plan for methoxyflurane (Penthrox and associated names) (EMEA-000334-PIP01-08-M11)
First published:
05/04/2024
https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000334-pip01-08-m11
I'm wondering if this indicates that the MAGPIE trial has been completed.
MEOF-002 - Methoxyflurane AnalGesia for Paediatric InjuriEs (MAGPIE)
https://clinicaltrials.gov/study/NCT03215056
https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004290-41/GB
I agree. The lack of communication is concerning. Are they not...
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.005(1.22%) |
Mkt cap ! $34.95M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 40.5¢ | 39.5¢ | $65.65K | 164.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1113 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 3632 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MVP (ASX) Chart |